Symbols / TNDM $18.61 -1.06% Tandem Diabetes Care, Inc.
TNDM Chart
About
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 1.27B |
| Enterprise Value | 1.43B | Income | -204.71M | Sales | 1.01B |
| Book/sh | 2.27 | Cash/sh | 4.28 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2500 | IPO | — |
| P/E | — | Forward P/E | -984.14 | PEG | — |
| P/S | 1.25 | P/B | 8.19 | P/C | — |
| EV/EBITDA | -23.62 | EV/Sales | 1.41 | Quick Ratio | 1.89 |
| Current Ratio | 2.55 | Debt/Eq | 289.60 | LT Debt/Eq | — |
| EPS (ttm) | -3.04 | EPS next Y | -0.02 | EPS Growth | — |
| Revenue Growth | 2.70% | Earnings | 2026-05-07 | ROA | -5.28% |
| ROE | -97.89% | ROIC | — | Gross Margin | 53.81% |
| Oper. Margin | 2.86% | Profit Margin | -20.17% | Shs Outstand | 68.33M |
| Shs Float | 62.59M | Short Float | 21.30% | Short Ratio | 3.49 |
| Short Interest | — | 52W High | 29.65 | 52W Low | 9.98 |
| Beta | 1.74 | Avg Volume | 2.04M | Volume | 1.01M |
| Target Price | $30.76 | Recom | Buy | Prev Close | $18.81 |
| Price | $18.61 | Change | -1.06% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-19 | up | Truist Securities | Hold → Buy | $35 |
| 2026-03-17 | up | Piper Sandler | Neutral → Overweight | $33 |
| 2026-03-02 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $25 |
| 2026-02-23 | up | Lake Street | Hold → Buy | $50 |
| 2026-02-23 | reit | Truist Securities | Hold → Hold | $27 |
| 2026-02-20 | main | Mizuho | Neutral → Neutral | $22 |
| 2026-02-20 | main | UBS | Neutral → Neutral | $22 |
| 2026-02-20 | main | Stifel | Hold → Hold | $22 |
| 2026-02-20 | up | B of A Securities | Underperform → Neutral | $30 |
| 2026-02-20 | main | Piper Sandler | Neutral → Neutral | $21 |
| 2026-02-04 | main | Stifel | Hold → Hold | $20 |
| 2026-01-09 | main | Bernstein | Market Perform → Market Perform | $25 |
| 2025-12-18 | main | Truist Securities | Hold → Hold | $24 |
| 2025-12-17 | main | Canaccord Genuity | Buy → Buy | $35 |
| 2025-12-17 | main | Mizuho | Neutral → Neutral | $21 |
| 2025-12-16 | up | Baird | Neutral → Outperform | $30 |
| 2025-12-11 | main | Citigroup | Neutral → Neutral | $22 |
| 2025-12-02 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $23 |
| 2025-11-10 | main | Barclays | Overweight → Overweight | $55 |
| 2025-11-10 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $17 |
- Tandem Diabetes Care Stock Slides -26% With A 8-Day Losing Spree - trefis.com Fri, 03 Apr 2026 04
- Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - finance.yahoo.com Wed, 01 Apr 2026 20
- Tandem Diabetes schedules May 7 earnings call, webcast at 4:30 p.m. ET - Stock Titan hu, 02 Apr 2026 20
- Is It Time To Revisit Tandem Diabetes Care (TNDM) After Recent Share Price Weakness? - simplywall.st hu, 02 Apr 2026 15
- JPMorgan Chase & Co. Sells 203,183 Shares of Tandem Diabetes Care, Inc. $TNDM - MarketBeat Fri, 03 Apr 2026 09
- Tandem stock rises on Q4 beats, new pay-as-you-go model - drugdeliverybusiness.com hu, 19 Feb 2026 08
- 3 Reasons to Sell TNDM and 1 Stock to Buy Instead - StockStory Wed, 18 Mar 2026 07
- Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness - finance.yahoo.com Sat, 04 Apr 2026 19
- Tandem Diabetes Care Stock Plummets 26% With 8-Day Losing Streak - trefis.com Fri, 03 Apr 2026 04
- Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance UK Sat, 04 Apr 2026 08
- Tandem Diabetes Care Stock In Shambles: Down 25% With 7-Day Losing Streak - trefis.com hu, 02 Apr 2026 05
- Why Are Tandem Diabetes (TNDM) Shares Soaring Today - finance.yahoo.com ue, 17 Mar 2026 07
- TNDM Q4 Earnings & Revenues Beat Estimates, Gross Margin & Stock Up - finance.yahoo.com Fri, 20 Feb 2026 08
- Why Are Tandem Diabetes (TNDM) Shares Soaring Today - finance.yahoo.com Fri, 20 Feb 2026 08
- Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength? - finance.yahoo.com Wed, 18 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
1,014.74
+7.93%
|
940.20
+25.74%
|
747.72
-6.68%
|
801.22
|
| Operating Revenue |
|
1,014.74
+7.93%
|
940.20
+25.74%
|
747.72
-6.68%
|
801.22
|
| Cost Of Revenue |
|
468.72
+4.02%
|
450.63
+18.58%
|
380.03
-2.11%
|
388.23
|
| Reconciled Cost Of Revenue |
|
468.72
+4.02%
|
450.63
+18.58%
|
380.03
-2.11%
|
388.23
|
| Gross Profit |
|
546.01
+11.53%
|
489.57
+33.15%
|
367.69
-10.97%
|
412.99
|
| Operating Expense |
|
713.32
+21.17%
|
588.70
-2.03%
|
600.92
+18.80%
|
505.83
|
| Research And Development |
|
268.33
+34.92%
|
198.88
-19.94%
|
248.42
+46.00%
|
170.15
|
| Selling General And Administration |
|
444.99
+14.15%
|
389.82
+10.59%
|
352.50
+5.01%
|
335.68
|
| Total Expenses |
|
1,182.04
+13.73%
|
1,039.33
+5.95%
|
980.95
+9.72%
|
894.07
|
| Operating Income |
|
-167.31
-68.78%
|
-99.13
+57.50%
|
-233.23
-151.20%
|
-92.85
|
| Total Operating Income As Reported |
|
-187.26
-88.91%
|
-99.13
+57.50%
|
-233.23
-151.20%
|
-92.85
|
| EBITDA |
|
-176.56
-153.12%
|
-69.75
+64.49%
|
-196.46
-164.74%
|
-74.21
|
| Normalized EBITDA |
|
-156.61
-128.67%
|
-68.49
+65.14%
|
-196.46
-164.22%
|
-74.36
|
| Reconciled Depreciation |
|
17.67
+6.38%
|
16.61
+5.68%
|
15.71
+9.67%
|
14.33
|
| EBIT |
|
-194.22
-124.90%
|
-86.36
+59.30%
|
-212.18
-139.64%
|
-88.54
|
| Total Unusual Items |
|
-19.95
-1473.42%
|
-1.27
|
0.00
-100.00%
|
0.15
|
| Total Unusual Items Excluding Goodwill |
|
-19.95
-1473.42%
|
-1.27
|
0.00
-100.00%
|
0.15
|
| Special Income Charges |
|
-19.95
-1473.42%
|
-1.27
|
0.00
|
0.00
|
| Other Special Charges |
|
19.95
+1473.42%
|
1.27
-98.39%
|
78.75
+153.71%
|
31.04
|
| Net Income |
|
-204.71
-113.18%
|
-96.03
+56.86%
|
-222.61
-135.33%
|
-94.59
|
| Pretax Income |
|
-200.27
-117.99%
|
-91.87
+58.29%
|
-220.25
-137.21%
|
-92.85
|
| Net Non Operating Interest Income Expense |
|
1.18
-88.85%
|
10.58
-18.48%
|
12.98
+8636.84%
|
-0.15
|
| Interest Expense Non Operating |
|
6.05
+9.77%
|
5.51
-31.81%
|
8.08
+87.32%
|
4.31
|
| Net Interest Income |
|
1.18
-88.85%
|
10.58
-18.48%
|
12.98
+8636.84%
|
-0.15
|
| Interest Expense |
|
6.05
+9.77%
|
5.51
-31.81%
|
8.08
+87.32%
|
4.31
|
| Interest Income Non Operating |
|
9.09
-49.50%
|
17.99
-21.28%
|
22.86
+277.38%
|
6.06
|
| Interest Income |
|
9.09
-49.50%
|
17.99
-21.28%
|
22.86
+277.38%
|
6.06
|
| Other Income Expense |
|
-34.15
-928.15%
|
-3.32
+95.78%
|
-78.75
-53671.43%
|
0.15
|
| Gain On Sale Of Security |
|
—
|
—
|
—
|
0.15
|
| Tax Provision |
|
4.44
+6.81%
|
4.16
+76.28%
|
2.36
+35.30%
|
1.74
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-4.19
-1473.42%
|
-0.27
|
0.00
-100.00%
|
0.03
|
| Net Income Including Noncontrolling Interests |
|
-204.71
-113.18%
|
-96.03
+56.86%
|
-222.61
-135.33%
|
-94.59
|
| Net Income From Continuing Operation Net Minority Interest |
|
-204.71
-113.18%
|
-96.03
+56.86%
|
-222.61
-135.33%
|
-94.59
|
| Net Income From Continuing And Discontinued Operation |
|
-204.71
-113.18%
|
-96.03
+56.86%
|
-222.61
-135.33%
|
-94.59
|
| Net Income Continuous Operations |
|
-204.71
-113.18%
|
-96.03
+56.86%
|
-222.61
-135.33%
|
-94.59
|
| Normalized Income |
|
-188.95
-98.84%
|
-95.02
+57.31%
|
-222.61
-135.04%
|
-94.71
|
| Net Income Common Stockholders |
|
-204.71
-113.18%
|
-96.03
+56.86%
|
-222.61
-135.33%
|
-94.59
|
| Diluted EPS |
|
-3.04
-106.80%
|
-1.47
+57.14%
|
-3.43
-133.33%
|
-1.47
|
| Basic EPS |
|
-3.04
-106.80%
|
-1.47
+57.14%
|
-3.43
-133.33%
|
-1.47
|
| Basic Average Shares |
|
67.28
+2.80%
|
65.45
+0.74%
|
64.97
+1.28%
|
64.15
|
| Diluted Average Shares |
|
67.28
+2.80%
|
65.45
+0.74%
|
64.97
+1.28%
|
64.15
|
| Diluted NI Availto Com Stockholders |
|
-204.71
-113.18%
|
-96.03
+56.86%
|
-222.61
-135.33%
|
-94.59
|
| Earnings From Equity Interest |
|
-14.19
-591.38%
|
-2.05
|
0.00
|
0.00
|
| Total Other Finance Cost |
|
1.86
-2.41%
|
1.91
+5.71%
|
1.80
-4.91%
|
1.90
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
881.11
-8.94%
|
967.66
+1.57%
|
952.66
-9.51%
|
1,052.79
|
| Current Assets |
|
618.14
-14.68%
|
724.49
-3.14%
|
747.99
-12.00%
|
849.98
|
| Cash Cash Equivalents And Short Term Investments |
|
292.67
-33.23%
|
438.33
-6.32%
|
467.91
-24.15%
|
616.90
|
| Cash And Cash Equivalents |
|
90.63
+30.91%
|
69.23
+17.61%
|
58.87
-65.88%
|
172.52
|
| Cash Equivalents |
|
—
|
—
|
—
|
—
|
| Cash Financial |
|
—
|
—
|
—
|
—
|
| Other Short Term Investments |
|
202.03
-45.26%
|
369.10
-9.77%
|
409.04
-7.95%
|
444.38
|
| Receivables |
|
165.49
+44.43%
|
114.58
+8.55%
|
105.56
-7.99%
|
114.72
|
| Accounts Receivable |
|
165.49
+44.43%
|
114.58
+8.55%
|
105.56
-7.99%
|
114.72
|
| Gross Accounts Receivable |
|
173.88
+42.72%
|
121.84
+10.31%
|
110.45
-7.22%
|
119.04
|
| Allowance For Doubtful Accounts Receivable |
|
-8.39
-15.75%
|
-7.25
-48.04%
|
-4.90
-13.20%
|
-4.33
|
| Inventory |
|
128.77
-13.93%
|
149.61
-5.27%
|
157.94
+42.14%
|
111.12
|
| Raw Materials |
|
31.77
-2.55%
|
32.60
-23.80%
|
42.78
+9.12%
|
39.21
|
| Work In Process |
|
23.80
-28.98%
|
33.52
-23.87%
|
44.03
+137.07%
|
18.57
|
| Finished Goods |
|
73.19
-12.34%
|
83.49
+17.38%
|
71.13
+33.35%
|
53.34
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
31.22
+42.12%
|
21.96
+32.44%
|
16.59
+129.04%
|
7.24
|
| Total Non Current Assets |
|
262.97
+8.14%
|
243.17
+18.81%
|
204.67
+0.92%
|
202.81
|
| Net PPE |
|
179.75
+9.97%
|
163.46
-0.53%
|
164.33
-8.29%
|
179.18
|
| Gross PPE |
|
252.80
+11.72%
|
226.28
+4.22%
|
217.13
-7.74%
|
235.35
|
| Accumulated Depreciation |
|
-73.05
-16.27%
|
-62.83
-19.01%
|
-52.79
+6.02%
|
-56.17
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
17.23
-20.33%
|
21.62
-2.52%
|
22.18
-15.02%
|
26.10
|
| Other Properties |
|
99.27
+20.70%
|
82.25
+18.19%
|
69.59
+10.82%
|
62.80
|
| Leases |
|
136.30
+11.34%
|
122.41
-2.35%
|
125.36
-14.41%
|
146.45
|
| Goodwill And Other Intangible Assets |
|
11.72
+1167.03%
|
0.93
-66.68%
|
2.78
-40.00%
|
4.63
|
| Other Intangible Assets |
|
11.72
+1167.03%
|
0.93
-66.68%
|
2.78
-40.00%
|
4.63
|
| Investments And Advances |
|
60.35
-19.04%
|
74.55
|
0.00
|
—
|
| Long Term Equity Investment |
|
60.35
-19.04%
|
74.55
|
0.00
|
—
|
| Other Non Current Assets |
|
11.15
+162.82%
|
4.24
-88.71%
|
37.56
+97.64%
|
19.00
|
| Total Liabilities Net Minority Interest |
|
725.94
+3.03%
|
704.56
+10.26%
|
639.03
+4.27%
|
612.84
|
| Current Liabilities |
|
242.72
-1.75%
|
247.05
+26.52%
|
195.26
+18.13%
|
165.29
|
| Payables And Accrued Expenses |
|
68.08
+8.23%
|
62.90
+0.94%
|
62.31
-4.61%
|
65.33
|
| Payables |
|
47.07
+5.22%
|
44.73
-9.79%
|
49.59
-11.02%
|
55.73
|
| Accounts Payable |
|
47.07
+5.22%
|
44.73
-9.79%
|
49.59
-11.02%
|
55.73
|
| Current Accrued Expenses |
|
21.01
+15.64%
|
18.17
+42.78%
|
12.73
+32.63%
|
9.60
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
70.41
+9.79%
|
64.13
+47.66%
|
43.43
+12.27%
|
38.68
|
| Current Debt And Capital Lease Obligation |
|
19.47
-66.93%
|
58.88
+245.12%
|
17.06
+30.02%
|
13.12
|
| Current Debt |
|
—
|
40.67
|
—
|
—
|
| Other Current Borrowings |
|
—
|
40.67
|
—
|
—
|
| Current Capital Lease Obligation |
|
19.47
+6.94%
|
18.21
+6.73%
|
17.06
+30.02%
|
13.12
|
| Current Deferred Liabilities |
|
9.53
-19.47%
|
11.83
-73.11%
|
43.99
+133.55%
|
18.84
|
| Current Deferred Revenue |
|
9.53
-19.47%
|
11.83
-73.11%
|
43.99
+133.55%
|
18.84
|
| Other Current Liabilities |
|
75.24
+52.57%
|
49.31
+73.26%
|
28.46
-2.94%
|
29.32
|
| Total Non Current Liabilities Net Minority Interest |
|
483.22
+5.62%
|
457.51
+3.10%
|
443.77
-0.84%
|
447.55
|
| Long Term Debt And Capital Lease Obligation |
|
425.00
+2.49%
|
414.69
+4.03%
|
398.61
-2.00%
|
406.76
|
| Long Term Debt |
|
310.04
+0.57%
|
308.27
+8.15%
|
285.04
+0.64%
|
283.23
|
| Long Term Capital Lease Obligation |
|
114.97
+8.03%
|
106.42
-6.30%
|
113.57
-8.06%
|
123.52
|
| Non Current Deferred Liabilities |
|
8.47
-18.95%
|
10.46
-21.57%
|
13.33
-21.00%
|
16.87
|
| Non Current Deferred Revenue |
|
8.47
-18.95%
|
10.46
-21.57%
|
13.33
-21.00%
|
16.87
|
| Other Non Current Liabilities |
|
49.74
+53.67%
|
32.37
+1.69%
|
31.83
+33.08%
|
23.92
|
| Stockholders Equity |
|
155.17
-41.02%
|
263.10
-16.11%
|
313.63
-28.71%
|
439.95
|
| Common Stock Equity |
|
155.17
-41.02%
|
263.10
-16.11%
|
313.63
-28.71%
|
439.95
|
| Capital Stock |
|
0.07
+3.03%
|
0.07
+0.00%
|
0.07
+1.54%
|
0.07
|
| Common Stock |
|
0.07
+3.03%
|
0.07
+0.00%
|
0.07
+1.54%
|
0.07
|
| Share Issued |
|
68.29
+3.06%
|
66.26
+1.09%
|
65.55
+1.61%
|
64.51
|
| Ordinary Shares Number |
|
68.29
+3.06%
|
66.26
+1.09%
|
65.55
+1.61%
|
64.51
|
| Additional Paid In Capital |
|
1,402.04
+6.80%
|
1,312.80
+3.86%
|
1,264.00
+7.95%
|
1,170.89
|
| Retained Earnings |
|
-1,252.54
-19.54%
|
-1,047.83
-10.09%
|
-951.80
-30.53%
|
-729.19
|
| Gains Losses Not Affecting Retained Earnings |
|
5.59
+387.26%
|
-1.95
-242.22%
|
1.37
+175.34%
|
-1.82
|
| Other Equity Adjustments |
|
5.59
+387.26%
|
-1.95
-242.22%
|
1.37
+175.34%
|
-1.82
|
| Total Equity Gross Minority Interest |
|
155.17
-41.02%
|
263.10
-16.11%
|
313.63
-28.71%
|
439.95
|
| Total Capitalization |
|
465.21
-18.58%
|
571.36
-4.56%
|
598.67
-17.22%
|
723.18
|
| Working Capital |
|
375.42
-21.37%
|
477.44
-13.62%
|
552.73
-19.27%
|
684.69
|
| Invested Capital |
|
465.21
-23.99%
|
612.03
+2.23%
|
598.67
-17.22%
|
723.18
|
| Total Debt |
|
444.48
-6.14%
|
473.56
+13.93%
|
415.67
-1.00%
|
419.88
|
| Net Debt |
|
219.40
-21.56%
|
279.70
+23.67%
|
226.17
+104.28%
|
110.72
|
| Capital Lease Obligations |
|
134.44
+7.87%
|
124.63
-4.60%
|
130.63
-4.40%
|
136.65
|
| Net Tangible Assets |
|
143.45
-45.28%
|
262.17
-15.66%
|
310.86
-28.59%
|
435.32
|
| Tangible Book Value |
|
143.45
-45.28%
|
262.17
-15.66%
|
310.86
-28.59%
|
435.32
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-9.72
-140.13%
|
24.23
+176.16%
|
-31.81
-163.04%
|
50.46
|
| Cash Flow From Continuing Operating Activities |
|
-9.72
-140.13%
|
24.23
+176.16%
|
-31.81
-163.04%
|
50.46
|
| Net Income From Continuing Operations |
|
-204.71
-113.18%
|
-96.03
+56.86%
|
-222.61
-135.33%
|
-94.59
|
| Depreciation Amortization Depletion |
|
17.67
+6.38%
|
16.61
+5.68%
|
15.71
+9.67%
|
14.33
|
| Depreciation |
|
15.10
+2.72%
|
14.70
+6.52%
|
13.80
+12.20%
|
12.30
|
| Amortization Cash Flow |
|
2.50
+31.58%
|
1.90
+0.00%
|
1.90
-5.00%
|
2.00
|
| Depreciation And Amortization |
|
17.67
+6.38%
|
16.61
+5.68%
|
15.71
+9.67%
|
14.33
|
| Amortization Of Intangibles |
|
2.50
+31.58%
|
1.90
+0.00%
|
1.90
-5.00%
|
2.00
|
| Other Non Cash Items |
|
88.14
+2778.41%
|
3.06
-96.80%
|
95.57
+130.34%
|
41.49
|
| Stock Based Compensation |
|
92.38
-8.88%
|
101.38
+15.11%
|
88.08
+3.72%
|
84.92
|
| Provisionand Write Offof Assets |
|
9.48
-5.02%
|
9.98
+80.13%
|
5.54
+15.85%
|
4.78
|
| Asset Impairment Charge |
|
—
|
—
|
—
|
7.57
|
| Deferred Tax |
|
—
|
—
|
—
|
0.00
|
| Deferred Income Tax |
|
—
|
—
|
—
|
0.00
|
| Operating Gains Losses |
|
14.19
+327.40%
|
3.32
|
—
|
-0.15
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
-0.15
|
| Change In Working Capital |
|
-23.04
-95.56%
|
-11.78
+33.38%
|
-17.68
-280.40%
|
-4.65
|
| Change In Receivables |
|
-56.81
-173.20%
|
-20.80
-586.21%
|
4.28
+154.62%
|
-7.83
|
| Changes In Account Receivables |
|
-56.81
-173.20%
|
-20.80
-586.21%
|
4.28
+154.62%
|
-7.83
|
| Change In Inventory |
|
24.82
+327.13%
|
5.81
+112.62%
|
-46.05
-8.48%
|
-42.45
|
| Change In Prepaid Assets |
|
-9.09
-63.31%
|
-5.57
+39.11%
|
-9.14
-15656.90%
|
-0.06
|
| Change In Payables And Accrued Expense |
|
1.56
-50.51%
|
3.16
+235.71%
|
-2.33
-109.68%
|
24.03
|
| Change In Accrued Expense |
|
-0.66
-111.96%
|
5.55
+118.76%
|
2.54
+650.33%
|
-0.46
|
| Change In Payable |
|
2.23
+193.10%
|
-2.39
+50.82%
|
-4.86
-119.86%
|
24.49
|
| Change In Account Payable |
|
2.23
+193.10%
|
-2.39
+50.82%
|
-4.86
-119.86%
|
24.49
|
| Change In Other Working Capital |
|
1.21
+108.70%
|
-13.88
-151.99%
|
26.69
+691.71%
|
-4.51
|
| Change In Other Current Assets |
|
-6.89
-871.33%
|
0.89
+128.02%
|
-3.19
-164.04%
|
-1.21
|
| Change In Other Current Liabilities |
|
22.16
+19.19%
|
18.59
+54.29%
|
12.05
-55.98%
|
27.38
|
| Investing Cash Flow |
|
72.88
+410.35%
|
-23.48
+72.61%
|
-85.74
-358.50%
|
33.17
|
| Cash Flow From Continuing Investing Activities |
|
72.88
+410.35%
|
-23.48
+72.61%
|
-85.74
-358.50%
|
33.17
|
| Net PPE Purchase And Sale |
|
-19.95
-3.73%
|
-19.23
+28.25%
|
-26.80
+21.39%
|
-34.10
|
| Purchase Of PPE |
|
-19.95
-3.73%
|
-19.23
+28.25%
|
-26.80
+21.39%
|
-34.10
|
| Capital Expenditure |
|
-98.54
-412.38%
|
-19.23
+80.03%
|
-96.30
-182.43%
|
-34.10
|
| Net Investment Purchase And Sale |
|
171.41
+4132.27%
|
-4.25
-140.26%
|
10.56
-88.64%
|
92.98
|
| Purchase Of Investment |
|
-85.66
+72.43%
|
-310.71
+41.99%
|
-535.66
-12.41%
|
-476.51
|
| Sale Of Investment |
|
257.07
-16.12%
|
306.46
-43.89%
|
546.22
-4.09%
|
569.49
|
| Net Business Purchase And Sale |
|
—
|
0.00
+100.00%
|
-69.50
-170.20%
|
-25.72
|
| Purchase Of Business |
|
—
|
0.00
+100.00%
|
-69.50
-170.20%
|
-25.72
|
| Net Intangibles Purchase And Sale |
|
-78.59
|
0.00
+100.00%
|
-69.50
-684.82%
|
-8.86
|
| Purchase Of Intangibles |
|
-78.59
|
0.00
+100.00%
|
-69.50
-684.82%
|
-8.86
|
| Financing Cash Flow |
|
-43.37
-618.31%
|
8.37
+103.43%
|
4.11
-75.63%
|
16.88
|
| Cash Flow From Continuing Financing Activities |
|
-43.37
-618.31%
|
8.37
+103.43%
|
4.11
-75.63%
|
16.88
|
| Net Issuance Payments Of Debt |
|
-40.76
-167.12%
|
60.73
|
0.00
|
0.00
|
| Issuance Of Debt |
|
0.00
-100.00%
|
306.85
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-40.76
+83.44%
|
-246.12
|
0.00
|
0.00
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
306.85
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-40.76
+83.44%
|
-246.12
|
0.00
|
0.00
|
| Net Long Term Debt Issuance |
|
-40.76
-167.12%
|
60.73
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
0.00
+100.00%
|
-30.00
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
-2.61
+61.26%
|
-6.73
-260.85%
|
4.18
-76.05%
|
17.47
|
| Net Other Financing Charges |
|
—
|
-15.63
-21914.08%
|
-0.07
+88.01%
|
-0.59
|
| Changes In Cash |
|
19.79
+117.21%
|
9.11
+108.03%
|
-113.44
-212.86%
|
100.51
|
| Effect Of Exchange Rate Changes |
|
1.61
+28.34%
|
1.26
+692.45%
|
-0.21
-125.63%
|
0.83
|
| Beginning Cash Position |
|
69.23
+17.61%
|
58.87
-65.88%
|
172.52
+142.36%
|
71.18
|
| End Cash Position |
|
90.63
+30.91%
|
69.23
+17.61%
|
58.87
-65.88%
|
172.52
|
| Free Cash Flow |
|
-108.26
-2267.74%
|
4.99
+103.90%
|
-128.11
-882.73%
|
16.37
|
| Interest Paid Supplemental Data |
|
5.05
+64.14%
|
3.08
-59.34%
|
7.57
+75.40%
|
4.31
|
| Income Tax Paid Supplemental Data |
|
5.06
+63.20%
|
3.10
+61.10%
|
1.92
+367.88%
|
0.41
|
| Amortization Of Securities |
|
-3.83
-64.93%
|
-2.32
-164.71%
|
3.59
-14.33%
|
4.19
|
| Earnings Losses From Equity Investments |
|
14.19
+591.38%
|
2.05
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-18 View
- 42026-03-09 View
- 8-K2026-02-27 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-19 View
- 10-K2026-02-19 View
- 8-K2026-02-19 View
- 42026-01-20 View
- 8-K2025-12-30 View
- 42025-12-17 View
- 42025-12-17 View
- 42025-12-08 View
- 42025-11-25 View
- 42025-11-19 View
- 42025-11-19 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|